GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Incannex Healthcare Ltd (STU:IQI) » Definitions » Net Margin %

Incannex Healthcare (STU:IQI) Net Margin % : 0.00% (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Incannex Healthcare Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Incannex Healthcare's Net Income for the three months ended in Mar. 2024 was €-5.55 Mil. Incannex Healthcare's Revenue for the three months ended in Mar. 2024 was €0.00 Mil. Therefore, Incannex Healthcare's net margin for the quarter that ended in Mar. 2024 was 0.00%.

The historical rank and industry rank for Incannex Healthcare's Net Margin % or its related term are showing as below:


STU:IQI's Net Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 3.53
* Ranked among companies with meaningful Net Margin % only.

Incannex Healthcare Net Margin % Historical Data

The historical data trend for Incannex Healthcare's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incannex Healthcare Net Margin % Chart

Incannex Healthcare Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -291.05 -230.82 -776.69 -598.99 -

Incannex Healthcare Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Incannex Healthcare's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Incannex Healthcare's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Incannex Healthcare's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Incannex Healthcare's Net Margin % distribution charts can be found below:

* The bar in red indicates where Incannex Healthcare's Net Margin % falls into.



Incannex Healthcare Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Incannex Healthcare's Net Margin for the fiscal year that ended in Jun. 2022 is calculated as

Net Margin=Net Income (A: Jun. 2022 )/Revenue (A: Jun. 2022 )
=-9.699/0
= %

Incannex Healthcare's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin=Net Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-5.549/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Incannex Healthcare  (STU:IQI) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Incannex Healthcare Net Margin % Related Terms

Thank you for viewing the detailed overview of Incannex Healthcare's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Incannex Healthcare (STU:IQI) Business Description

Traded in Other Exchanges
Address
8 Century Circuit Norwest, Suite 105, Sydney, NSW, AUS, 3000
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.